BioNTech SE (BNTX)
NASDAQ: BNTX
· Real-Time Price · USD
98.74
-0.33 (-0.33%)
At close: May 23, 2025, 3:59 PM
98.68
-0.06%
After-hours: May 23, 2025, 05:21 PM EDT
BioNTech SE Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Other Sales Revenue | 319M |
| Other Sales Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Germany Revenue | 706.9M | 482.7M | 12.71B | 2.24B | 20.6M |
| Germany Revenue Growth | +46.45% | -96.20% | +466.92% | +10783.01% | n/a |
| Rest Of The World Revenue | 196.4M | 3.01B | n/a | 14.64B | n/a |
| Rest Of The World Revenue Growth | -93.48% | n/a | n/a | n/a | n/a |
| United States Revenue | 1.85B | n/a | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 120.6M | 132.1M | 150.5M | 183.8M | 132.6M | 149.4M | 153.5M | 137.9M | 131.6M | 137.5M | 153.8M | 148.1M | 105.1M | 145.9M | 76.9M | 59.8M | 47.6M | 35.66M | 27.59M | 20.25M | 15.2M | 7.02M | 11.25M | 13.74M | 8.86M | 8.88M | 7.33M | 5.44M | 5.44M |
| Selling, General, and Administrative Revenue Growth | -8.71% | -12.23% | -18.12% | +38.61% | -11.24% | -2.67% | +11.31% | +4.79% | -4.29% | -10.60% | +3.85% | +40.91% | -27.96% | +89.73% | +28.60% | +25.63% | +33.47% | +29.25% | +36.27% | +33.24% | +116.45% | -37.60% | -18.13% | +55.04% | -0.23% | +21.25% | +34.69% | 0.00% | n/a |
| Research and Development Revenue | 525.6M | 611.8M | 550.3M | 584.6M | 507.5M | 577.8M | 497.9M | 372.58M | 330.65M | 485.89M | 351.11M | 405.8M | 289.75M | 273.02M | 260.4M | 201.1M | 216.2M | 259.05M | 227.71M | 95.19M | 65.12M | 65.43M | 50.4M | 53.4M | 57.24M | 51.8M | 32.79M | 29.23M | 29.23M |
| Research and Development Revenue Growth | -14.09% | +11.18% | -5.87% | +15.19% | -12.17% | +16.05% | +33.64% | +12.68% | -31.95% | +38.39% | -13.48% | +40.05% | +6.13% | +4.85% | +29.49% | -6.98% | -16.54% | +13.76% | +139.21% | +46.17% | -0.47% | +29.83% | -5.63% | -6.71% | +10.51% | +57.96% | +12.19% | 0.00% | n/a |
| Sales and Marketing Revenue | 13.7M | 21.3M | 18.1M | 12.9M | 15.6M | 18M | 14.4M | 18.1M | 12.2M | 14.6M | 12.8M | 17.8M | 14.3M | 17.9M | 10.5M | 13.3M | 8.7M | 6.7M | 4.27M | 3.05M | 486K | 810K | 670K | 678K | 560K | 1.06M | 769K | 607.5K | 607.5K |
| Sales and Marketing Revenue Growth | -35.68% | +17.68% | +40.31% | -17.31% | -13.33% | +25.00% | -20.44% | +48.36% | -16.44% | +14.06% | -28.09% | +24.48% | -20.11% | +70.48% | -21.05% | +52.87% | +29.77% | +57.08% | +39.75% | +528.40% | -40.00% | +20.90% | -1.18% | +21.07% | -47.02% | +37.45% | +26.58% | 0.00% | n/a |